Spain, France and the Netherlands receive an experimental Japanese vaccine against hantavirus
28/05/2026
1 min
Spain, France and the Netherlands will receive the first doses of a hantavirus vaccine to treat patients or conduct clinical trials, the European Commission announced this Thursday. The European Medicines Agency (EMA) has chosen favipiravir, an experimental Japanese vaccine.